Wereldhave N.V.

11.2.2025 07:00:00 CET | Globenewswire | Press release

Wereldhave Full-year results 2024

Wereldhave Full-year results 2024

Net profit 2024 at € 140m, highest since 2007
Direct result 2024 at € 1.76 per share, slightly above guidance of € 1.75
Despite Benelux bankruptcies, occupancy rate of core portfolio increased to 97.3%
Disposal of Dutch asset Winkelhof (€ 56m) around book value in 2025
Positive core portfolio valuations (+3.0%), primarily driven by increased market rents (ERVs)
Proposed dividend for 2024 at € 1.25 per share (+4.2%)
Outlook 2025 direct result per share € 1.70-1.80, including negative impact of Dutch taxation and disposal Winkelhof

Attachment

Documents

Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.

Jeito Capital Leads a USD 65 million Financing in ReproNovo to Develop Transformational Treatments in Reproductive Medicine and Women’s Health

Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary

New funds secured – allowing the commercial ramp-up of QUVIVIQ to accelerate Idorsia’s path to profitability

Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers

CoinShares Expands XBT Provider Platform with Seven New Physical Crypto ETPs

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.